Testing effectiveness (Phase 2)Ended earlyNCT04081103
What this trial is testing
NEXAGON for the Treatment of Corneal Persistent Epithelial Defects Following Severe Ocular Injuries
Who this might be right for
Corneal Persistent Epithelial Defect
Glaukos Corporation 35